{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Differentiation",
      "Fracture",
      "Osteoblast",
      "SARS-CoV-2",
      "miR-4485"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33867845",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "25"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.7150/ijbs.56657"
    ],
    "Journal": {
      "ISSN": "1449-2288",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "5",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "International journal of biological sciences",
      "ISOAbbreviation": "Int J Biol Sci"
    },
    "ArticleTitle": "SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing.",
    "Pagination": {
      "StartPage": "1277",
      "EndPage": "1288",
      "MedlinePgn": "1277-1288"
    },
    "Abstract": {
      "AbstractText": [
        "The angiotensin-converting enzyme 2 (ACE2) receptor has been identified as the cell entry point for SARS-CoV-2. Although ACE2 receptors are present in the bone marrow, the effects of SARS-CoV-2 on the biological activity of bone tissue have not yet been elucidated. In the present study we sought to investigate the impact of SARS-CoV-2 on osteoblastic activity in the context of fracture healing. MicroRNA-4485 (miR-4485), which we found to be upregulated in COVID-19 patients, negatively regulates osteogenic differentiation. We demonstrate this effect both <i>in vitro</i> and <i>in vivo</i>. Moreover, we identified the toll-like receptor 4 (TLR-4) as the potential target gene of miR-4485, and showed that reduction of TLR-4 induced by miR-4485 suppresses osteoblastic differentiation <i>in vitro</i>. Taken together, our findings highlight that up-regulation of miR-4485 is responsible for the suppression of osteogenic differentiation in COVID-19 patients, and TLR-4 is the potential target through which miR-4485 acts, providing a promising target for pro-fracture-healing and anti-osteoporosis therapy in COVID-19 patients."
      ],
      "CopyrightInformation": "\u00a9 The author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Mi",
        "ForeName": "Bobin",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Xiong",
        "ForeName": "Yuan",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Chenming",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Zhou",
        "ForeName": "Wu",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Lang",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Cao",
        "ForeName": "Faqi",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Fenghua",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Geng",
        "ForeName": "Zhi",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston 02115, USA."
          }
        ],
        "LastName": "Panayi",
        "ForeName": "Adriana C",
        "Initials": "AC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Sun",
        "ForeName": "Yun",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Lin",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei 430022, China."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Guohui",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Australia",
    "MedlineTA": "Int J Biol Sci",
    "NlmUniqueID": "101235568",
    "ISSNLinking": "1449-2288"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN4485 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MicroRNAs"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "TLR4 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Toll-Like Receptor 4"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "ACE2 protein, human"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Differentiation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fracture Healing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "MicroRNAs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Osteogenesis"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Toll-Like Receptor 4"
    }
  ],
  "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."
}